Nishitani Shinobu, Matsumura Tsuyoshi, Fujitani Shoji, Sonaka Ichiro, Miura Yutaka, Yagasaki Kazumi
Pharmaceutical Research Laboratories, Ajinomoto Co., Inc., 1-1, Suzuki-cho, Kawasaki-ku, Kawasaki-shi, Kanagawa 210-8681, Japan.
Biochem Biophys Res Commun. 2002 Dec 20;299(5):693-6. doi: 10.1016/s0006-291x(02)02717-1.
Soleus muscles isolated from normal rats were incubated to evaluate whether or not leucine promotes glucose uptake under insulin-free conditions, using a labeled 2-deoxyglucose uptake assay. Glucose uptake was promoted by 2mM leucine. A metabolite of leucine, alpha-ketoisocaproic acid (alpha-KIC), also exhibited a similar stimulatory effect, although this was not as potent as leucine. Stimulation of glucose uptake by leucine was completely canceled by pre-treatment with either 10 microM LY294002, a specific inhibitor of phosphatidylinositol 3-kinase (PI3-kinase), or 6 microM GF109203X, a specific inhibitor of protein kinase C (PKC). No significant change was observed by pre-treatment with 1 microM rapamycin, a specific inhibitor of mammalian target of rapamycin (mTOR). These results suggest that leucine stimulates glucose transport in skeletal muscle via PI3-kinase and PKC pathways independently of the mammalian target of mTOR. They also suggest that leucine stimulates glucose transport by an insulin-independent mechanism.
从正常大鼠分离出比目鱼肌,使用标记的2-脱氧葡萄糖摄取试验进行孵育,以评估在无胰岛素条件下亮氨酸是否促进葡萄糖摄取。2mM亮氨酸可促进葡萄糖摄取。亮氨酸的一种代谢产物α-酮异己酸(α-KIC)也表现出类似的刺激作用,尽管其效力不如亮氨酸。用磷脂酰肌醇3-激酶(PI3-激酶)的特异性抑制剂10μM LY294002或蛋白激酶C(PKC)的特异性抑制剂6μM GF109203X预处理,可完全消除亮氨酸对葡萄糖摄取的刺激作用。用雷帕霉素的特异性抑制剂1μM雷帕霉素预处理未观察到显著变化,雷帕霉素是哺乳动物雷帕霉素靶蛋白(mTOR)的特异性抑制剂。这些结果表明,亮氨酸通过PI3-激酶和PKC途径刺激骨骼肌中的葡萄糖转运,独立于哺乳动物雷帕霉素靶蛋白(mTOR)。它们还表明亮氨酸通过胰岛素非依赖机制刺激葡萄糖转运。